Cyclophosphamide-Free Adjuvant Chemotherapy for Ovarian Protection in Young Women With Breast Cancer: A Randomized Phase 3 Trial.
Jinha YuJing-Yu GeXi-Yu LiuMiao MoMin HeZhi-Ming Shaonull nullPublished in: Journal of the National Cancer Institute (2022)
The cyclophosphamide-free chemotherapy regimen might be associated with a higher probability of menses resumption.